The risk of resistance emerging during the treatment of tuberculosis (TB) is ever present. The simultaneous detection of both ethambutol-sensitive and -resistant genotypes in sputum specimens predicted or known to have drug-resistant TB has been reported, a phenomenon described as heteroresistance. We extend this observation by detecting pre-existing mutants in the sputum of patients from a population in Tanzania in which resistance is unlikely.